Biocryst Pharmaceuticals (BCRX) Gross Margin Growth (1y) (2013 - 2026)
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Gross Margin Growth (1y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 484.00 |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 96.00 |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | -93.00 |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | -91.00 |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 210.00 |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 1,966.00 |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | -475.00 |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | -553.00 |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -1,260.00 |
| 10 | Biocryst Pharmaceuticals | 2.29 Bn | 1.94 Bn | 214.41 Mn | -5.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.00 |
| Mar 31, 2026 | -30.00 |
| Dec 31, 2025 | -134,028.00 |
| Sep 30, 2025 | 137.00 |
| Jun 30, 2025 | -16.00 |
| Mar 31, 2025 | -178.00 |
| Dec 31, 2024 | -297.00 |
| Sep 30, 2024 | -148.00 |
| Jun 30, 2024 | -47.00 |
| Mar 31, 2024 | -1.00 |
| Dec 31, 2023 | 133.00 |
| Sep 30, 2023 | 341.00 |
| Jun 30, 2023 | -71.00 |
| Mar 31, 2023 | -88.00 |
| Dec 31, 2022 | -211.00 |
| Sep 30, 2022 | -323.00 |
| Jun 30, 2022 | 22.00 |
| Mar 31, 2022 | 3,060.00 |
| Dec 31, 2021 | -6.00 |
| Sep 30, 2021 | 2,342.00 |